BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kleefeld F, Heller S, Ingiliz P, Jessen H, Petersen A, Kopp U, Kraft A, Hahn K. Interferon-free therapy in hepatitis C virus (HCV) monoinfected and HCV/HIV coinfected patients: effect on cognitive function, fatigue, and mental health. J Neurovirol. 2018;24:557-569. [PMID: 29785584 DOI: 10.1007/s13365-018-0647-z] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
Number Citing Articles
1 Santos-Lima C, Souza-Marques B, Vieira F, Isabel Schinoni M, Quarantini LC, Abreu N. Neuropsychological effects of direct-acting antiviral treatment for Hepatitis C virus subjects: A systematic review. J Viral Hepat 2021. [PMID: 34320255 DOI: 10.1111/jvh.13584] [Reference Citation Analysis]
2 Chan T, Marta M, Hawkins C, Rackstraw S. Cognitive and Neurologic Rehabilitation Strategies for Central Nervous System HIV Infection. Curr HIV/AIDS Rep 2020;17:514-21. [PMID: 32844275 DOI: 10.1007/s11904-020-00515-0] [Reference Citation Analysis]
3 Gascon MRP, Benute GRG, Macedo EC, CapitÃo CG, Vidal JE, Smid J, Marcusso RMN, Lucia MCS, Penalva-DE-Oliveira AC, Diament D. Cognitive assessment in patients with Hepatitis C submitted to treatment with Sofosbuvir and Simeprevir or Daclatasvir. Arq Neuropsiquiatr 2020;78:342-8. [PMID: 32609193 DOI: 10.1590/0004-282X20200022] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Lions C, Laroche H, Zaegel-Faucher O, Ressiot E, Bregigeon S, Geneau de Lamarliere P, Solas C, Tamalet C, Pieve MA, Ritleng AS, Debreux C, Ivanova A, Obry-Roguet V, Carrieri P, Poizot-Martin I. Hepatitis C virus-microelimination program and patient trajectories after hepatitis C virus cure in an outpatient HIV clinical unit. Eur J Gastroenterol Hepatol 2020;32:1212-21. [PMID: 31851097 DOI: 10.1097/MEG.0000000000001640] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
5 Margusino-Framiñán L, Bobadilla-Pérez E, Cid-Silva P, Rodríguez-Sotelo A, Yáñez-Rubal JC, Mena-de-Cea Á, Suárez-López F, Prieto-Pérez A, Giménez-Arufe V, Delgado-Blanco M, Sanclaudio-Luhia AI, Martín-Herranz I, Castro-Iglesias Á. Effectiveness and safety of direct-acting antivirals in hepatitis C infected patients with mental disorders: Results in real clinical practice. J Med Virol 2020. [PMID: 32181917 DOI: 10.1002/jmv.25772] [Reference Citation Analysis]
6 Bar N, Levy S, Deutsch L, Leshno M, Rabinowich L, Younis F, Shibolet O, Katchman H. Hepatitis C related cognitive impairment: Impact of viral and host factors and response to therapy. J Viral Hepat 2021;28:870-7. [PMID: 33624351 DOI: 10.1111/jvh.13492] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Kleefeld F, Arendt G, Neuen-Jacob E, Maschke M, Husstedt I, Obermann M, Schmidt H, Hahn K; Deutsche Gesellschaft für Neuro-AIDS und Neuro-Infektiologie (DGNANI). [Neurological complications of hepatitis C infections]. Nervenarzt 2021;92:144-9. [PMID: 33001263 DOI: 10.1007/s00115-020-00999-6] [Reference Citation Analysis]
8 Tagliapietra M, Monaco S. Neuroimaging Findings in Chronic Hepatitis C Virus Infection: Correlation with Neurocognitive and Neuropsychiatric Manifestations. Int J Mol Sci. 2020;21. [PMID: 32252497 DOI: 10.3390/ijms21072478] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
9 Bladowska J, Pawłowski T, Fleischer-Stępniewska K, Knysz B, Małyszczak K, Żelwetro A, Rymer W, Inglot M, Waliszewska-Prosół M, Ejma M, Podgórski P, Zimny A, Sąsiadek M. Interferon-free therapy as the cause of white matter tracts and cerebral perfusion recovery in patients with chronic hepatitis C. J Viral Hepat 2019;26:635-43. [PMID: 30702208 DOI: 10.1111/jvh.13069] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
10 Vold JH, Gjestad R, Aas CF, Chalabianloo F, Skurtveit S, Løberg EM, Johansson KA, Fadnes LT; INTRO-HCV Study Group. Impact of clinical and sociodemographic factors on fatigue among patients with substance use disorder: a cohort study from Norway for the period 2016-2020. Subst Abuse Treat Prev Policy 2020;15:93. [PMID: 33317568 DOI: 10.1186/s13011-020-00334-x] [Reference Citation Analysis]
11 Faccioli J, Nardelli S, Gioia S, Riggio O, Ridola L. Neurological and psychiatric effects of hepatitis C virus infection. World J Gastroenterol 2021; 27(29): 4846-4861 [PMID: 34447230 DOI: 10.3748/wjg.v27.i29.4846] [Reference Citation Analysis]
12 Goutzamanis S, Spelman T, Harney B, Dietze P, Stoove M, Higgs P, Thompson A, Doyle JS, Hellard M. Patient-reported outcomes of the Treatment and Prevention Study: A real-world community-based trial of direct-acting antivirals for hepatitis C among people who inject drugs. J Viral Hepat 2021;28:1068-77. [PMID: 33880820 DOI: 10.1111/jvh.13516] [Reference Citation Analysis]
13 Sun B, Abadjian L, Monto A, Freasier H, Pulliam L. Hepatitis C Virus Cure in Human Immunodeficiency Virus Coinfection Dampens Inflammation and Improves Cognition Through Multiple Mechanisms. J Infect Dis 2020;222:396-406. [PMID: 32157304 DOI: 10.1093/infdis/jiaa109] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
14 Goutzamanis S, Doyle J, Higgs P, Hellard M. Improving hepatitis C direct-acting antiviral access and uptake: A role for patient-reported outcomes and lived experience. J Viral Hepat 2019;26:218-23. [PMID: 30315689 DOI: 10.1111/jvh.13020] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
15 Amirsardari Z, Rahmani F, Rezaei N. Cognitive impairments in HCV infection: From pathogenesis to neuroimaging. J Clin Exp Neuropsychol 2019;41:987-1000. [PMID: 31405320 DOI: 10.1080/13803395.2019.1652728] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
16 Pericot-Valverde I, Heo M, Niu J, Norton BL, Akiyama MJ, Agyemang L, Litwin AH. Declines in Depressive Symptoms Among People who Inject Drugs Treated With Direct-Acting Antivirals While on Opioid Agonist Therapy. Open Forum Infect Dis 2020;7:ofaa380. [PMID: 33381611 DOI: 10.1093/ofid/ofaa380] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
17 Vaghi G, Gori B, Strigaro G, Burlone M, Minisini R, Barbaglia MN, Brigatti E, Varrasi C, Pirisi M, Cantello R. Direct antivirals and cognitive impairment in hepatitis C: a clinical-neurophysiologic study. J Neurovirol. 2020;26:870-879. [PMID: 32910431 DOI: 10.1007/s13365-020-00904-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]